MedGenome Appoints Industry Veterans Felix Olale, M.D., Ph.D., as CEO and Jennifer Rose as Chief Commercial Officer to Lead U.S. Expansion

MedGenome, a global leader in multiomics and precision medicine, today announced the appointment of two distinguished executives to lead its U.S. operations. Felix Olale, M.D., Ph.D., has been named President and Chief Executive Officer, and Jennifer Rose joins as Executive Vice President and Chief Commercial Officer. Together, these seasoned industry veterans will fuel MedGenome’s expansion in North America, advancing its mission to provide unparalleled insights into disease mechanisms, biomarkers, and personalized medicine through cutting-edge multiomics solutions.